Literature DB >> 7795591

Spectrum of germline mutations in the RB1 gene: a study of 232 patients with hereditary and non hereditary retinoblastoma.

V Blanquet1, C Turleau, M S Gross-Morand, C Sénamaud-Beaufort, F Doz, C Besmond.   

Abstract

Germline mutations in the RB1 gene confer hereditary predisposition to retinoblastoma. We have performed a mutation survey of the RB1 gene in 232 patients with hereditary or non hereditary retinoblastoma. We systematically explored all 27 exons and flanking sequences as well as the promotor. All types of point mutations are represented and are found unequally distributed along the RB1 gene sequence. In the population we studied, exons 3, 8, 18 and 19 are preferentially altered. The range of frequency of detection of germline mutations is about 20%, indicating that other mechanisms of inactivation of RB1 should be involved. The spectrum of mutations presented here should help to improve the clinical management of retinoblastoma and to understand the molecular mechanisms leading to tumorigenesis.

Entities:  

Mesh:

Year:  1995        PMID: 7795591     DOI: 10.1093/hmg/4.3.383

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  33 in total

1.  Two new mutations and three novel polymorphisms in the RB1 gene in Ecuadorian patients.

Authors:  Paola E Leone; María Elena Vega; Paola Jervis; Angel Pestaña; Javier Alonso; César Paz-Y-Miño
Journal:  J Hum Genet       Date:  2003-11-19       Impact factor: 3.172

2.  Molecular subgrouping of primary pineal parenchymal tumors reveals distinct subtypes correlated with clinical parameters and genetic alterations.

Authors:  Elke Pfaff; Christian Aichmüller; Martin Sill; Damian Stichel; Matija Snuderl; Matthias A Karajannis; Martin U Schuhmann; Jens Schittenhelm; Martin Hasselblatt; Christian Thomas; Andrey Korshunov; Marina Rhizova; Andrea Wittmann; Anna Kaufhold; Murat Iskar; Petra Ketteler; Dietmar Lohmann; Brent A Orr; David W Ellison; Katja von Hoff; Martin Mynarek; Stefan Rutkowski; Felix Sahm; Andreas von Deimling; Peter Lichter; Marcel Kool; Marc Zapatka; Stefan M Pfister; David T W Jones
Journal:  Acta Neuropathol       Date:  2019-11-25       Impact factor: 17.088

3.  The spectrum of RB1 germ-line mutations in hereditary retinoblastoma.

Authors:  D R Lohmann; B Brandt; W Höpping; E Passarge; B Horsthemke
Journal:  Am J Hum Genet       Date:  1996-05       Impact factor: 11.025

4.  Constitutional RB1-gene mutations in patients with isolated unilateral retinoblastoma.

Authors:  D R Lohmann; M Gerick; B Brandt; U Oelschläger; B Lorenz; E Passarge; B Horsthemke
Journal:  Am J Hum Genet       Date:  1997-08       Impact factor: 11.025

Review 5.  [Soft tissue tumors in hereditary tumor syndromes].

Authors:  A Agaimy
Journal:  Pathologe       Date:  2017-05       Impact factor: 1.011

6.  Cost comparison of molecular versus conventional screening of relatives at risk for retinoblastoma.

Authors:  H Z Noorani; H N Khan; B L Gallie; A S Detsky
Journal:  Am J Hum Genet       Date:  1996-08       Impact factor: 11.025

7.  Predictive testing for retinoblastoma comes of age.

Authors:  B L Gallie
Journal:  Am J Hum Genet       Date:  1997-08       Impact factor: 11.025

8.  Characterization of mutations in patients with multiple endocrine neoplasia type 1.

Authors:  J H Bassett; S A Forbes; A A Pannett; S E Lloyd; P T Christie; C Wooding; B Harding; G M Besser; C R Edwards; J P Monson; J Sampson; J A Wass; M H Wheeler; R V Thakker
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

9.  Crystal structure of the retinoblastoma protein N domain provides insight into tumor suppression, ligand interaction, and holoprotein architecture.

Authors:  Markus Hassler; Shradha Singh; Wyatt W Yue; Maciej Luczynski; Rachid Lakbir; Francisco Sanchez-Sanchez; Thomas Bader; Laurence H Pearl; Sibylle Mittnacht
Journal:  Mol Cell       Date:  2007-11-09       Impact factor: 17.970

10.  Identification and characterization of retinoblastoma gene mutations disturbing apoptosis in human breast cancers.

Authors:  Elisabet Ognedal Berge; Stian Knappskog; Stephanie Geisler; Vidar Staalesen; Marec Pacal; Anne-Lise Børresen-Dale; Pål Puntervoll; Johan Richard Lillehaug; Per Eystein Lønning
Journal:  Mol Cancer       Date:  2010-07-01       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.